ArticleAnnals of the rheumatic diseases2024

Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.

Abigail E Schiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.